DE234227C - - Google Patents
Info
- Publication number
- DE234227C DE234227C DENDAT234227D DE234227DA DE234227C DE 234227 C DE234227 C DE 234227C DE NDAT234227 D DENDAT234227 D DE NDAT234227D DE 234227D A DE234227D A DE 234227DA DE 234227 C DE234227 C DE 234227C
- Authority
- DE
- Germany
- Prior art keywords
- bacilli
- acid
- vaccines
- solution
- hand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000052616 bacterial pathogen Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 7
- 229960005486 vaccine Drugs 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000031711 Cytophagaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- NIPLIJLVGZCKMP-UHFFFAOYSA-M Neurine Chemical compound [OH-].C[N+](C)(C)C=C NIPLIJLVGZCKMP-UHFFFAOYSA-M 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000003956 methylamines Chemical class 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
DE234227C true DE234227C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Family
ID=494100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT234227D Active DE234227C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE234227C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1148703B (de) * | 1959-11-26 | 1963-05-16 | Ortho Pharma Corp | Verfahren zur Herstellung eines Impfstoffes gegen Brucellose |
-
0
- DE DENDAT234227D patent/DE234227C/de active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1148703B (de) * | 1959-11-26 | 1963-05-16 | Ortho Pharma Corp | Verfahren zur Herstellung eines Impfstoffes gegen Brucellose |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69103944T2 (de) | Durchsichtiger Stift. | |
DE2215181B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE2821585A1 (de) | Abschminkmittel, neue darin verwendete verbindungen und verfahren zu deren herstellung | |
DE234227C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE2241667C3 (de) | Stabiles pharmazeutisches Mittel in Form einer wässrigen oralen anwendbaren Suspension | |
AT88675B (de) | Verfahren zur Herstellung von spezifischen Impfstoffen aus Reinkulturen von Mikroorganismen. | |
AT52934B (de) | Verfahren zur Gewinnung wirksamer Impfstoffe aus Bakterien. | |
DE397888C (de) | Verfahren zur Herstellung von spezifischen Impfstoffen aus Reinkulturen von Mikroorganismen | |
Tiedemann et al. | Embryonale Induktion und Hemmung der Ribonucleinsäure-Synthese durch Actinomycin D | |
DE1568320A1 (de) | Kosmetisches Wasser,in der menschlichen Haut retinierendes Mittel,auf hautphysiologischer Basis und Verfahren zu seiner Herstellung | |
DE638839C (de) | Verfahren zur Herstellung waessrig-alkoholischer Cholesterinloesungen | |
DE254769C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE650751C (de) | Verfahren zur Herstellung haltbarer, glykolhaltiger Loesungen von Alkalisalzen der Barbitursaeureabkoemmlinge | |
DE642980C (de) | Verfahren zur Herstellung von therapeutisch wirksamen Loesungen aus Bakterien | |
DE227793C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE951756C (de) | Verfahren zur Herstellung konzentrierter haltbarer waessriger Loesungen von Furanochromonen | |
DE107735C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE338166C (de) | Verfahren zur Herstellung unschaedlicher Impfstoffe aus gifthaltigen pathogenen Mikroorganismen | |
DE2602882A1 (de) | Haarwasser | |
DE721051C (de) | Verfahren zum Weichmachen von Textilgut aus Cellulose- oder Cellulosehydratfasern | |
DE217788C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE657129C (de) | Verfahren zur Herstellung von Loesungen oder Extrakten aus Bakterien, Pollen oder sonstigen pflanzlichen Zellen | |
DE3706484A1 (de) | Viruzide und spermizide mit einem gehalt an quaternaeren ammoniumsalzen | |
DE431369C (de) | Herstellung von Farbstofftinten | |
DE434264C (de) | Verfahren zur Darstellung eines therapeutisch wirksamen Praeparats aus Digitalisblaettern |